Personalized Non-invasive Neuromodulation by rTMS for Chronic and Treatment Resistant Catatonia
NCT03116425 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17
Last updated 2022-04-20
Summary
Investigators hypothesize that personalizing rTMS targets using functional MRI will allow to improve symptoms of patients suffering from chronic catatonia.
Conditions
- Schizophreniform Catatonia
- Treatment Resistant
Interventions
- DEVICE
-
Individualized rTMS on VERUM 1's region or network
To increase cortical rCBF, iTB (intermittent theta burst) will be used: triplet at 50 Hz repeated at 5 Hz in trains of 2 sec with an inter-train interval of 8 sec. To decrease cortical rCBF, cTB (continuous theta burst) will be used: triplet at 50 Hz repeated at 5 Hz in trains of 40 sec. Intensity 120% of passive threshold (or 150% of active threshold). Stimulation protocol will be used up to 5 times per session to allow a reasonable regional or network coverage. Patients will have 4 sessions per day on 5 successive days per arm.
- DEVICE
-
Individualized rTMS on VERUM 2's region or network
To increase cortical rCBF, iTB (intermittent theta burst) will be used: triplet at 50 Hz repeated at 5 Hz in trains of 2 sec with an inter-train interval of 8 sec. To decrease cortical rCBF, cTB (continuous theta burst) will be used: triplet at 50 Hz repeated at 5 Hz in trains of 40 sec. Intensity 120% of passive threshold (or 150% of active threshold). Stimulation protocol will be used up to 5 times per session to allow a reasonable regional or network coverage. Patients will have 4 sessions per day on 5 successive days per arm.
- DEVICE
-
Individualized rTMS on PLACEBO region
Region will be modulated up or down according to the stimulation protocol used in VERUM 1 and 2 conditions. Stimulation will be replicated up to 5 times per session. Patients will have 4 sessions per day on 5 successive days per arm.
- PROCEDURE
-
Individualized rTMS on VERUM 1's region or network
To increase cortical rCBF, iTB (intermittent theta burst) will be used: triplet at 50 Hz repeated at 5 Hz in trains of 2 sec with an inter-train interval of 8 sec. To decrease cortical rCBF, cTB (continuous theta burst) will be used: triplet at 50 Hz repeated at 5 Hz in trains of 40 sec. Intensity 120% of passive threshold (or 150% of active threshold). Stimulation protocol will be used up to 5 times per session to allow a reasonable regional or network coverage. Patients will have 4 sessions per day on 5 successive days per arm.
- PROCEDURE
-
Individualized rTMS on VERUM 2's region or network
To increase cortical rCBF, iTB (intermittent theta burst) will be used: triplet at 50 Hz repeated at 5 Hz in trains of 2 sec with an inter-train interval of 8 sec. To decrease cortical rCBF, cTB (continuous theta burst) will be used: triplet at 50 Hz repeated at 5 Hz in trains of 40 sec. Intensity 120% of passive threshold (or 150% of active threshold). Stimulation protocol will be used up to 5 times per session to allow a reasonable regional or network coverage. Patients will have 4 sessions per day on 5 successive days per arm.
- PROCEDURE
-
Individualized rTMS on PLACEBO region
Region will be modulated up or down according to the stimulation protocol used in VERUM 1 and 2 conditions. Stimulation will be replicated up to 5 times per session. Patients will have 4 sessions per day on 5 successive days per arm.
Sponsors & Collaborators
-
University Hospital, Strasbourg, France
lead OTHER
Principal Investigators
-
Jack FOUCHER, MD · Hôpitaux Universitaires de Strasbourg
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-04-24
- Primary Completion
- 2022-06-30
- Completion
- 2022-06-30
Countries
- France
Study Locations
More Related Trials
-
e-PAT Neuromod Evaluation of Personalized rTMS for Resistant Depression
NCT02410421 ·Status: WITHDRAWN ·Phase: PHASE2
-
Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Negative Symptoms in Schizophrenia
NCT00783120 ·Status: COMPLETED ·Phase: NA
-
rTMS to Target Neural Connectivity and Rumination in Treatment-Resistant Depression
NCT06511544 ·Status: RECRUITING ·Phase: NA
-
Cerebellar rTMS for the Treatment of Schizophrenic Patients
NCT01072617 ·Status: COMPLETED ·Phase: NA
-
Multimodal MRI-guided rTMS to Treat Refractory Hallucinations
NCT01373866 ·Status: COMPLETED ·Phase: NA
-
Modulation of Repetitive Transcranial Magnetic Stimulation on Hippocampal Neurogenesis and Functional Network in Patients With Schizophrenia
NCT03608462 ·Status: UNKNOWN ·Phase: NA
-
High Frequency rTMS Treatment for Cognitive Impairments in Chronic Schizophrenia Patients
NCT03774927 ·Status: COMPLETED ·Phase: NA
-
Structural and Functional Correlates of Clinical Response to rTMS Treatment in Schizophrenia Patients With Resistant Auditory Hallucinations
NCT02755623 ·Status: UNKNOWN ·Phase: NA
-
Symptom Evaluation Following Repetitive Transcranial Magnetic Stimulation
NCT06429748 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
rTMS for Emotional Difficulties in Verterans
NCT03749967 ·Status: COMPLETED ·Phase: PHASE1
-
rTMS-induced Cumulative Pattern of sBDNF in Chronic Schizophrenia
NCT01427088 ·Status: COMPLETED ·Phase: NA
-
Magnetic Stimulation of the Brain in Schizophrenia or Depression
NCT02905604 ·Status: COMPLETED ·Phase: NA
-
Exploration of the Deep Transcranial Magnetic Stimulation for Treatment Resistant Schizophrenia
NCT05167942 ·Status: UNKNOWN ·Phase: NA
-
Influence of rTMS on Symptoms and Cognitive Function in Patients With Psychiatric Disorders
NCT04055181 ·Status: COMPLETED ·Phase: NA
-
rTMS and Functional Paralysis
NCT01352910 ·Status: COMPLETED ·Phase: NA
-
Transcranial Magnetic Stimulation (TMS) for Patients With Treatment Resistant Auditory Verbal Hallucination
NCT03762746 ·Status: UNKNOWN ·Phase: PHASE3
-
tRNS in Anterior Cingulate Cortex Reduces Craving Over Dual Pathology Patients
NCT01876524 ·Status: COMPLETED ·Phase: NA
-
rTMS Add on Value for Amelioration of Negative Symptoms of Schizophrenia
NCT04318977 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Neuromodulation of Social Cognitive Circuitry in People With Schizophrenia Spectrum Disorders
NCT04418011 ·Status: COMPLETED ·Phase: NA
-
rTMS Treatment for Positive and Negative Symptoms of Schizophrenia
NCT03413527 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
rTMS as a Probe of Episodic Memory Neurocircuitry in Schizophrenia
NCT04182113 ·Status: COMPLETED ·Phase: NA
-
Personalized rTMS for Resistant Depression
NCT02863380 ·Status: TERMINATED ·Phase: NA
-
Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of First Rank Symptoms (FRS) on Schizophrenia
NCT03284138 ·Status: COMPLETED ·Phase: NA
-
Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment for Schizophrenia Patients With Auditory Hallucinations
NCT02863094 ·Status: COMPLETED ·Phase: NA
-
rTMS-tACS Stimulation on Improving Cognitive Function in Bipolar Disorder
NCT05964777 ·Status: UNKNOWN ·Phase: NA